Cellulitis resident survival guide: Difference between revisions

Jump to navigation Jump to search
Line 108: Line 108:
==Do's==
==Do's==


*The content in this section is in bullet points.
* Supportive care including elevation of the limb and adequate moisturizing of the site of the cellulitis should be done. The elevation of the limb promotes venous and lymphatic drainage from the site. Moisturize the affected site with emollients and moisturizers. It will hydrate the skin and prevent breakouts.<ref name="pmid24947530">{{cite journal| author=Stevens DL, Bisno AL, Chambers HF, Dellinger EP, Goldstein EJ, Gorbach SL | display-authors=etal| title=Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the infectious diseases society of America. | journal=Clin Infect Dis | year= 2014 | volume= 59 | issue= 2 | pages= 147-59 | pmid=24947530 | doi=10.1093/cid/ciu296 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24947530  }} </ref>
* Physicians should prescribe antibiotics to the patients according to body weight. Obese or lymphedema patients can be given a lower dose than their body weight. This results in inadequate response and failure of the treatment.
* The duration of antibiotic treatment is variable and depends upon the clinical improvement of the cellulitis. Mostly, there is significant improvement within a day or two after the initiation of the antibiotics. The patient is given treatment for five days. The antibiotic course is given for two weeks in patients with systematic symptoms, low immunity, and rapidly progressive cellulitis.  
24947530 15302637


==Don'ts==
==Don'ts==

Revision as of 11:46, 23 October 2020


Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mydah Sajid, MD[2] Synonyms and keywords:

Overview

Causes

Life Threatening Causes

No known life-threatening causes are included.

Common Causes

The cellulitis is bacterial in origin caused by invasion of bacteria through the skin barrier. The common causes are:

Diagnosis

Shown below is an algorithm summarizing the diagnosis of cellulitis according to the Infectious Diseases Society of America guidelines.

 
 
 
Patients presents with clinical symptoms suggestive of cellulitis, i.e.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Perform compression Doppler ultrasound of the limb and D-dimers level
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Positive
 
Negative
 
 
 
 
 
 
 
 
 
 
 
 
likely Deep vein thrombosis (DVT)
 
DVT unlikely. High clinical suspicion for cellulitis
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Assess levels of inflammatory markers
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Raised ESR, CRP and leukocytosis
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Does patient have any signs of rapidly progressive or systemic infection?
  • Body temperature>101.5 degrees Fahrenheit, chills, headache, and fatigue
  • Signs of sepsis. i.e. hypotension and heart rate>100bpm
  • Patient develops rapidly progressive symptoms like bullae, vesicles, petechia, crepitus
  • Patient has low immunity (i.e. infants and elderly patients)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Perform the following tests:
  • Debridement of wound with culture of the specimen
  • Blood culture
  • Radiographic tests to evaluate deep tissue infection

Treatment

Shown below is an algorithm summarizing the treatment of cellulitis.[1]

 
 
 
 
 
 
 
Is the cellulitis having a purulent discharge?
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Yes
 
 
 
 
 
 
 
No
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Are there any of the following clinical signs?
  • Systemic toxicity (fever, hypotension, and tachycardia)
  • Presence of an indwelling device (pacemaker, vascular graft)
  • Patient is on extremes of age
  • Major comorbid conditions
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Yes
 
 
 
 
No
 
 
 
  • Incise and drain any discrete abscess.
  • Delay oral antibiotic therapy
  • Monitor patient for spontaneous resolution. If respone is inadequate then initiate oral antibiotic therapy
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Initiate intravenous antibiotic therapy. The coverage of the micro-organisms is determined by:
  • Oral or peri-rectal ulcers
  • Pressure ulcer with draining abscess
  • Necrosis of overlying skin
 
 
 
 
Initiate oral antibiotic therapy. The coverage of the micro-organisms is determined by:
  • Oral or peri-rectal ulcers
  • Pressure ulcer with draining abscess
  • Necrosis of overlying skin
  •  
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
    Yes
     
    No
     
    Yes
     
    No
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
    Initiate antibiotics that cover both MRSA and gram negative rods. To cover MRSA:
    • Vancomycin or
    • Daptomycin

    Plus one of the following to cover for gram negative rods

    • Ampicillin-Sulbactam
    • Piperacillin-Tazobactam
    • Ceftriaxone plus metronidazole
    • Levofloxacin plus metronidazole
     
    Infection most likely due to MRSA. Initiate
  • Vancomycin or
  • Daptomycin
  •  
    * Incision and drainage of discrete abscesses
  • Send drained specimen for culture and susceptibility
  • Start wide coverage empirical antibiotic covering MRSA, gram-negative bacilli, anaerobes, and gram-positive organisms. Regimens includes:
  • Trimethoprim-Sulfamethoxazole plus amoxicillin-clavulanate
  • Doxycycline plus levofloxacin plus metronidazole
  • Minocycline plus amoxicillin-clavulanate
  •  
    Assess patient's risk for infective endocarditis
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
    Yes
     
     
    No
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
    • Initiate empirical antibiotics coverage for MRSA and beta-hemolytic streptococci. Regimens include Trimethoprim-sulfamethoxazole or Doxycycline plus amoxicillin or Minocycline plus amoxicillin.
    • Incise and drain the abscess an hour after administration of the first dose of oral antibiotic.
    • Send the specimen for culture and sensitivity and start antibiotic accordingly after the results.
     
     
  • Incise and drain the discrete abscess
  • Send the specimen for culture and sensitivity
  • Initiate empirical antibiotics for MRSA. Regimens include Trimethoprim-sulfamethoxazole or Doxycycline or Minocycline
  •  
     
     

    Do's

    • Supportive care including elevation of the limb and adequate moisturizing of the site of the cellulitis should be done. The elevation of the limb promotes venous and lymphatic drainage from the site. Moisturize the affected site with emollients and moisturizers. It will hydrate the skin and prevent breakouts.[2]
    • Physicians should prescribe antibiotics to the patients according to body weight. Obese or lymphedema patients can be given a lower dose than their body weight. This results in inadequate response and failure of the treatment.
    • The duration of antibiotic treatment is variable and depends upon the clinical improvement of the cellulitis. Mostly, there is significant improvement within a day or two after the initiation of the antibiotics. The patient is given treatment for five days. The antibiotic course is given for two weeks in patients with systematic symptoms, low immunity, and rapidly progressive cellulitis.

    24947530 15302637

    Don'ts

    • The content in this section is in bullet points.

    References

    1. Miller LG, Quan C, Shay A, Mostafaie K, Bharadwa K, Tan N; et al. (2007). "A prospective investigation of outcomes after hospital discharge for endemic, community-acquired methicillin-resistant and -susceptible Staphylococcus aureus skin infection". Clin Infect Dis. 44 (4): 483–92. doi:10.1086/511041. PMID 17243049.
    2. Stevens DL, Bisno AL, Chambers HF, Dellinger EP, Goldstein EJ, Gorbach SL; et al. (2014). "Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the infectious diseases society of America". Clin Infect Dis. 59 (2): 147–59. doi:10.1093/cid/ciu296. PMID 24947530.